| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |